The Government of Telangana unveiled its Next-Gen Life Sciences Policy 2026-30 at the World Economic Forum 2026 in Davos, signalling the state's intent to play a far more consequential role in shaping the future of global healthcare, advanced therapeutics and sustainable bio-manufacturing.

The policy articulates a decisive shift from scale-driven manufacturing to value-led, innovation-powered growth and positions Telangana as a globally integrated life sciences hub across discovery, development and deployment. With a clear ambition to rank among the top five life sciences clusters worldwide by 2030, the policy targets USD 25 billion in investments, creation of 500,000 high-quality jobs and deeper integration into global life sciences value chains.

Several global sciences organisations — including Amgen, Sanofi, Bristol Myers Squibb and Lilly, among several others have established or expanded R&D, digital and Global Capability Centres (GCCs) in Hyderabad, reflecting confidence in the Telangana's scientific talent and innovation-ready infrastructure.

The Next-Gen Life Sciences Policy 2026-30 represents a deliberate scale-up, designed to accelerate Telangana's transition from being indispensable to global supply chains to becoming a global originator of advanced therapies and platforms. The policy was unveiled by the Chief Minister A Revanth Reddy in the presence of D Sridhar Babu, Minister for IT & Industries; Sanjay Kumar, Special Chief Secretary and Shakthi M Nagappan, IAS and CEO, Telangana Lifesciences.

"We are building one of the world's most trusted and transformational biosciences ecosystems—driving global health impact from Telangana. The policy's global unveiling at Davos reflects Telangana's conviction that the next phase of growth in life sciences will be driven by cross-border collaboration, global capital and shared innovation agendas," said A Revanth Reddy, Chief Minister, Telangana.

The policy implementation will be anchored by globally benchmarked infrastructure, including the Green Pharma City, 10 pharma villages, expansion of Genome Valley and further strengthening of the Medical Devices Park.

"The policy prioritises frontier science and advanced manufacturing platforms, including cell and gene therapies, peptides, precision fermentation and other next-generation modalities. It strengthens the broader ecosystem across clinical research, pharma services, diagnostics, medical electronics and digital health—positioning Telangana as a preferred destination for global life sciences hubs," said D Sridhar Babu, Minister for IT, Electronics & Communications, and Industries, Government of Telangana.

A dedicated Life Sciences Innovation Fund, scalable up to INR 1,000 crore (USD 100 million), will catalyse early- and growth-stage innovation, support deep-tech ventures and crowd in private and institutional capital. This is supported by the establishment of the Telangana School of Life Sciences, a university of global excellence focused on research, education and future-ready talent development.